Evaluation of Safer Sex Intervention (SSI)

Status Completed

Clinical Trial Summary

The purpose of the study is to determine the impact of the offer to participate in Safer Sex Intervention (SSI) (treatment) relative to the offer to participate in Female Sexual Health (control) on three self-reported sexual behaviors (condom use, other contraceptive use, and frequency of sex) six months after the end of treatment.

Clinical Trial Description

The Policy & Research Group (PRG) will be evaluating the Safer Sex Intervention (SSI). The Safer Sex Intervention is based in Social Cognitive Theory, the Transtheoretical Model of Behavior Change, and motivational interviewing. Coupled with skill-building exercises, the intervention is intended to increase knowledge related to risk and safe-sex behaviors, to increase awareness of risk and need for behavior change, to help build self-efficacy to engage in safe-sex behaviors, and, ultimately, to motivate participants to engage in and maintain safe sex practices. The intervention is meant to be delivered in four, one-on-one sessions over the course of six months. Each session is to be conducted in a private setting by a female health educator trained in motivational interviewing and Safer Sex Intervention. The initial or primary intervention session should take approximately 30 to 50 minutes. Subsequent "booster sessions" delivered 1, 3, and 6 months following the initial session are to take 10 to 30 minutes. Booster sessions are intended to sustain any resulting behavior change. The control (counterfactual) condition, Female Sexual Health, was developed specifically for use in this study; it consists of a 30-minute PowerPoint presentation, intended to be delivered in one face-to-face session that provides information about reproductive anatomy and STIs. After the presentation, participants receive free condoms. This is the only session for the control condition; there are no booster sessions. Though there were some variations in consent requirements across sites, there were no differences in the recruitment process between the treatment and control groups. All eligible individuals who provided the proper consent to participate were randomized and enrolled into the study at the time they attended their first scheduled study session. Data were collected via self-administered questionnaires that were scheduled at baseline and six months post treatment (12 months after baseline). The study took place in New Orleans, Louisiana, at five clinics that served young women between the ages of 14 and 19. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Teen Pregnancy Prevention

Clinical Trial Details

NCT number	NCT02544841
Study type	Interventional
Source	The Policy & Research Group
Contact
Status	Completed
Phase	N/A
Start date	February 2012
Completion date	August 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01698073` - Effect of a Culturally-based Intervention on Sexual Risky Behavior Among Young American Indian Adolescents	N/A
Completed	`NCT04508569` - Evaluation of Big Decisions in Three South Texas School Districts	N/A
Completed	`NCT04451031` - Evaluation of the Impact of Linking Families and Teens (LiFT) Curriculum	N/A
Recruiting	`NCT05569070` - Evaluation of Young United Parents	N/A
Completed	`NCT02816424` - Brief Intervention for Teen Pregnancy Prevention	N/A
Recruiting	`NCT03729726` - Future Foundation 2.0 Personal Responsibility Education Innovative Strategies (PREIS) Program	N/A
Active, not recruiting	`NCT03419728` - Federal Evaluation of Selected Programs for Expectant and Parenting Youth	N/A
Completed	`NCT02539589` - Evaluation of Becoming a Responsible Teen (BART)	N/A
Active, not recruiting	`NCT04798248` - Evaluation of Momentary Affect Regulation - Safer Sex Intervention	N/A
Completed	`NCT03238313` - Evaluation of "Plan A"	N/A
Completed	`NCT02957669` - Evaluation of Practice Self-Regulation	N/A
Completed	`NCT04863326` - Evaluation of the Making Proud Choices! Teen Pregnancy Prevention Program	N/A
Completed	`NCT04181034` - Impacts of the Positive Youth Development Program for Expectant and Parenting Teens in California	N/A
Completed	`NCT03242447` - Evaluation of e-Practice Self-Regulation (e-PS-R)	N/A
Recruiting	`NCT04044027` - Evaluation of the Spark of Duval Intervention	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.